Objectives: Early identification of Streptobacillus moniliformis infections that cause rat bite fever (RBF) can be challenging and treatment of these infections is important for the reduction of morbidity and mortality. We report a rapid and sensitive real-time PCR assay for use on whole blood (WB) specimens in less than 3 hrs.
INTRODUCTION
Streptobacillus moniliformis is a causative agent of rat bite fever (RBF), a rare zoonotic disease. It is a gram-negative, facultative, anaerobic bacillus that can be fastidious and difficult to isolate. Rats are considered the predominant reservoir for S. moniliformis, however animals that consume rats may also become infected or colonized [1, 2] . It is estimated that 50-100% of wild rats and 10-100% of domesticated rats are asymptomatically colonized with S. moniliformis [3] , and approximately 10% of rat bites result in infection [4] . Therefore, RBF and rat colonization with S. moniliformis represent important public health issues.
Over 200 cases of RBF have been documented in the United States [1] , however this is likely a significant under representation of disease burden since RBF is not a mandated nationally reportable disease. Over the past several decades, the likelihood of rodent-human interaction and chances of infection with RBF have increased as rats have gained popularity as pets, as use for reptile food, and wild rats have encroached into populated areas [5, 6] . More than 50% of infections occur in children; however laboratory personnel and pet shop employees are other high risk populations [1, 7] . Infections often result from animal bites, exposure to rat waste, or consumption of contaminated food and drink [8] [9] [10] . RBF often has a non-specific clinical presentation with a broad differential diagnosis, and identification and isolation of S. moniliformis is not always straightforward [1, 5, 11] and several new spcies have recently been described and compared to J Microbiol Infect Dis www.jmidonline.org Vol 7, No 2, June 2017 S. moniliformis [12] . Complications from RBF can include endocarditis, myocarditis, meningitis, pneumonia, or sepsis, and when left untreated the mortality rate is approximately 13% [13, 14] . Typically patients with RBF are treated with penicillin or tetracyclines [1, 5, 15] . Early identification of S. moniliformis is important for implementing immediate patient treatment to prevent severe disease and death [16, 17] , however few clinical laboratories have the ability to rapidly perform this testing on clinical specimens.
Due to the fastidious nature of this organism, culture from a primary specimen is not always feasible and 16S rDNA analysis (16S) has been the only method suitable for identification at the New York State (NYS) Department of Health Wadsworth Center laboratory. While accurate, 16S is labor intensive and has a long turnaround time, often greater than one week. PCR assays have been utilized [3, 18, 19] but these require running agarose gels which pose the potential for amplification contamination, and are not permitted as a stand-alone test for laboratory developed tests in New York State [20] . Therefore, we developed a TaqMan® real-time PCR assay that utilizes two fluorescently labeled target-specific probes that detect the 16S rRNA and gyrB genes and allows for rapid detection of S. moniliformis from whole blood (WB) in less than 3 hrs.
METHODS
Whole blood (WB) extraction was performed from 180 µl of specimen using the automated bioMerieux NucliSens easyMAG specific B D2 protocol. Prior to extraction, WB samples were seeded with 20ul of an assay specific inhibition control to assess extraction efficiency and inhibition [21] . Primer and probe sequences were designed to amplify unique sequences within the 16S and gyrB genes of the S. moniliformis genome (Table 1) . Real-time PCR utilized Quanta Multiplex SuperMix with the following thermal cycling conditions: 1 cycle at 95ºC for 3 min, 40 cycles at 95ºC for 15s and 60ºC for 45s in an ABI 7500 Real-time PCR instrument (Applied Biosystems). Real-time PCR results were interpreted with a reporting algorithm shown in Table 2 , and DNA sequencing was performed on all specimens to confirm the results using 16S rDNA sequence analysis as part of the assay validation. 
RESULTS
As expected in the specificity study, the 3 S. moniliformis strains tested were positive for both 16S and gyrB targets. The other Streptobacillus species were detected with the 16S target, and three of the four, S. felis, S. notomytis, and S. ratti were also detected with the gyrB target. However, the Ct value of the gyrB target was several Cts greater than that seen with the 16S target, indicating less specific binding of the primers and probe. The remaining 89 strains all tested negative for both targets demonstrating that the assay has no cross-reactivity with other bacterial species. The limit of detection for the real-time PCR assay was determined to be less than 1 CFU per PCR reaction from WB using a 10-fold dilution series of the DSM 12112 S. Inhibition control has Ct value >4.0 from the seeded negative extraction control, if result repeats it should be reported as indicated.
Re-extract and retest sample
Briefly, patients presented for medical attention on average 5 days from the onset of symptoms (range 2-10 days) and remained hospitalized with an average length of stay of 13 days (range 5-31 days). Data collected from retrospective chart reviews found the most commonly reported symptoms included fever (100%), chills (67%), rash on extremities (67%), vomiting (50%), difficulty walking (50%), nausea (50%), joint effusions (50%), body/muscle aches (50%), and joint pain (33%). Overall, 83% of patients had confirmed or probable rat exposure in the days or weeks prior to becoming ill. Patients were treated with varied intravenous and/or oral antibiotic regimens, predominantly from the penicillin and tetracycline classes, as indicated in Table 3 , and all six fully recovered. Testing performed on all patient samples demonstrated that the S. moniliformis real-time PCR assay can detect the organism from WB specimens and culture isolates as shown in Table 3 , when compared to 16S rDNA sequence analysis the results were 100% concordant (data not shown). 
DISCUSSION
In conclusion, this study describes a highly sensitive and specific real-time PCR assay for detection of S. moniliformis that meets the regulatory requirements for diagnostic testing in NYS [20] . It offers a rapid, accurate, and cost effective alternative to 16S analysis and conventional culture methods for identification.
Since culture of this organism from a primary specimen is not always successful this method also serves as a practical alternative to other methods of identification, such as MALDI-TOF MS. The six case studies presented here describe RBF cases from across NYS with detailed patient symptomology, exposure, and treatment information. This study highlights the J Microbiol Infect Dis www.jmidonline.org Vol 7, No 2, June 2017 need for detection of S. moniliformis as it is believed that known cases in the US represent a significant underestimation as neither the disease nor the isolation of the bacteria as reportable to health departments [1] .
Additionally, early identification of S. moniliformis is important for implementing timely patient treatment to prevent severe disease [1] and identification of other species of Streptobacillus may help to further our understanding of the contribution of these species as a public health threat [12] . This realtime PCR represents a valuable tool since it can be performed with instrumentation readily available in most public health and many clinical laboratories, providing results within 3 hours from receiving a WB specimen.
